CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 83 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2018. The put-call ratio across all filers is 1.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $109,000 | +12.4% | 20,000 | 0.0% | 0.02% | +5.0% |
| Q3 2019 | $97,000 | -32.6% | 20,000 | -3.8% | 0.02% | -31.0% |
| Q2 2019 | $144,000 | +2.1% | 20,780 | +2.4% | 0.03% | 0.0% |
| Q1 2019 | $141,000 | +18.5% | 20,300 | 0.0% | 0.03% | +7.4% |
| Q4 2018 | $119,000 | -22.2% | 20,300 | 0.0% | 0.03% | -12.9% |
| Q3 2018 | $153,000 | +48.5% | 20,300 | 0.0% | 0.03% | +55.0% |
| Q2 2018 | $103,000 | -16.9% | 20,300 | 0.0% | 0.02% | -23.1% |
| Q1 2018 | $124,000 | -13.9% | 20,300 | 0.0% | 0.03% | -10.3% |
| Q4 2017 | $144,000 | -0.7% | 20,300 | 0.0% | 0.03% | -6.5% |
| Q3 2017 | $145,000 | +11.5% | 20,300 | -1.7% | 0.03% | +3.3% |
| Q2 2017 | $130,000 | -22.6% | 20,660 | +1.5% | 0.03% | -26.8% |
| Q1 2017 | $168,000 | -0.6% | 20,360 | +1.8% | 0.04% | -12.8% |
| Q4 2016 | $169,000 | +24.3% | 20,000 | 0.0% | 0.05% | +20.5% |
| Q3 2016 | $136,000 | +126.7% | 20,000 | 0.0% | 0.04% | +116.7% |
| Q2 2016 | $60,000 | +233.3% | 20,000 | +100.0% | 0.02% | +200.0% |
| Q1 2016 | $18,000 | +5.9% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $17,000 | +6.2% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $16,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,738,925 | $23,555,000 | 31.22% |
| Perceptive Advisors | 1,232,500 | $7,764,000 | 0.39% |
| IFP Advisors, Inc | 1,001,025 | $6,306,000 | 0.27% |
| WOODSTOCK CORP | 55,489 | $350,000 | 0.07% |
| Virtus ETF Advisers LLC | 50,795 | $320,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 31,431 | $198,000 | 0.04% |
| Evanson Asset Management, LLC | 20,660 | $130,000 | 0.03% |
| Artal Group S.A. | 250,000 | $1,575,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 58,800 | $370,000 | 0.02% |
| Raymond James Financial Services Advisors, Inc. | 426,280 | $2,686,000 | 0.02% |